Could growth hormone ease gulf war illness symptoms?

NCT ID NCT05355272

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether growth hormone replacement therapy is safe and effective for veterans with Gulf War Illness who also have a growth hormone deficiency. Twenty veterans will receive the hormone for six months, and researchers will measure changes in belly fat, symptoms, and heart health risks. The goal is to see if a larger trial is worthwhile.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
recombinant human growth hormone (somatropin)
What this could lead to
If it works, this could point toward a treatment for growth hormone deficiency in veterans with Gulf War Illness, potentially reducing belly fat and improving symptoms.
What could go wrong
This is a small, early-phase trial with only 20 participants, so results may not apply to all veterans. Growth hormone therapy can have side effects like joint pain and fluid retention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT GROWTH HORMONE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Michael E. DeBakey VA Medical Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Email: •••••@•••••

    Contact

  • VA Puget Sound Healthcare System

    RECRUITING

    Seattle, Washington, 98108, United States

    Contact

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.